Q/C Technologies, Inc. Liabilities, Noncurrent
Q/C Technologies, Inc. (QCLS) had Liabilities, Noncurrent of $226.01 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Noncurrent $226.01K.
- 2026-03-31: Liabilities, Noncurrent $10.91M.
- 2025-12-31: Liabilities, Noncurrent $10.91M.
- 2025-09-30: Liabilities, Noncurrent $9.38M.
| Period end | Liabilities, Noncurrent | Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $226.01K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $10.91M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $10.91M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $9.38M 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $20.22M 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $279.62K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $100.54K 10-K · filed 2025-04-11 | |
| 2023-09-30 | $20.52K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $11.32M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $12.78M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $75.94K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $123.13K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $139.77K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $114.60K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $125.89K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $25.98K 10-Q/A · filed 2021-11-15 | |
| 2021-06-30 | $25.85K 10-Q · filed 2021-08-16 | |
| 2020-12-31 | $3.59M 10-K · filed 2022-03-31 | $2.38M 10-Q · filed 2021-08-16 |
| 2014-09-30 | $55.56K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $138.89K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $222.22K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $305.56K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |